TY - JOUR
T1 - Preparation of a solid-in-oil nanosuspension containing l-ascorbic acid as a novel long-term stable topical formulation
AU - Piao, Hongyu
AU - Kamiya, Noriho
AU - Cui, Fude
AU - Goto, Masahiro
N1 - Funding Information:
This work was supported in part by the Global COE Program “Science for Future Molecular Systems” from the Ministry of Education, Culture, Science, Sports and Technology of Japan (to M.G.).
PY - 2011/11/25
Y1 - 2011/11/25
N2 - l-Ascorbic acid (AA, vitamin C) easily decomposes into inactive compounds in aqueous solutions and this has limited its topical use. This work reports the preparation of a solid-in-oil nanosuspension (SONS) containing AA and validation of its basic storage stability. Although AA itself is water-soluble, it can readily be nanosuspended in squalane via complex formation involving a combination of sucrose erucate (i.e. lipophilic surfactant) and sucrose monolaureate (i.e. hydrophilic surfactant) to yield SONS with a very low moisture content (<500 ppm). To extract encapsulated AA, a lipase-based enzymatic degradation technique was used to degrade a formulation phase making it easier for AA to distribute into an extraction solution. Our results demonstrate that almost all the encapsulated AA (95.3%) was readily extracted from the SONS upon addition of medium-chain triglyceride, which offers the possibility of degrading the formulation phase using lipase. Finally, its storage stability study was investigated at 25 °C over 90 days under protection from light. An aqueous solution containing AA was used as a control. Compared with the control, the SONS markedly increased the stability of AA due to its low moisture content and, thus, the potential usefulness SONSs as a novel long-term stable topical formulation of AA has been proved.
AB - l-Ascorbic acid (AA, vitamin C) easily decomposes into inactive compounds in aqueous solutions and this has limited its topical use. This work reports the preparation of a solid-in-oil nanosuspension (SONS) containing AA and validation of its basic storage stability. Although AA itself is water-soluble, it can readily be nanosuspended in squalane via complex formation involving a combination of sucrose erucate (i.e. lipophilic surfactant) and sucrose monolaureate (i.e. hydrophilic surfactant) to yield SONS with a very low moisture content (<500 ppm). To extract encapsulated AA, a lipase-based enzymatic degradation technique was used to degrade a formulation phase making it easier for AA to distribute into an extraction solution. Our results demonstrate that almost all the encapsulated AA (95.3%) was readily extracted from the SONS upon addition of medium-chain triglyceride, which offers the possibility of degrading the formulation phase using lipase. Finally, its storage stability study was investigated at 25 °C over 90 days under protection from light. An aqueous solution containing AA was used as a control. Compared with the control, the SONS markedly increased the stability of AA due to its low moisture content and, thus, the potential usefulness SONSs as a novel long-term stable topical formulation of AA has been proved.
UR - http://www.scopus.com/inward/record.url?scp=80054709243&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80054709243&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2011.08.025
DO - 10.1016/j.ijpharm.2011.08.025
M3 - Article
C2 - 21878376
AN - SCOPUS:80054709243
SN - 0378-5173
VL - 420
SP - 156
EP - 160
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
IS - 1
ER -